AVNS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AVNS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.
Avanos Medical's quarterly accumulated depreciation increased from Sep. 2023 ($-118.3 Mil) to Dec. 2023 ($-122.9 Mil) and increased from Dec. 2023 ($-122.9 Mil) to Mar. 2024 ($-126.5 Mil).
Avanos Medical's annual accumulated depreciation declined from Dec. 2021 ($-136.2 Mil) to Dec. 2022 ($-104.8 Mil) but then increased from Dec. 2022 ($-104.8 Mil) to Dec. 2023 ($-122.9 Mil).
The historical data trend for Avanos Medical's Accumulated Depreciation can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avanos Medical Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Accumulated Depreciation | Get a 7-Day Free Trial |
![]() |
![]() |
-98.70 | -114.10 | -136.20 | -104.80 | -122.90 |
Avanos Medical Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Accumulated Depreciation | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-161.90 | -115.60 | -118.30 | -122.90 | -126.50 |
The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.
Thank you for viewing the detailed overview of Avanos Medical's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.
Sudhakar Varshney | officer: SVP, Global Supply Chain | 5405 WINDWARD PARKWAY, SUITE 100 SOUTH, ALPHARETTA GA 30004 |
Lisa Egbuonu-davis | director | C/O OMEGA HEALTHCARE INVESTORS, INC., 303 INTERNATIONAL CIRCLE, SUITE 200, HUNT VALLEY MD 21030 |
John Joseph Hurley | officer: Principal Accounting Officer | 5405 WINDWARD PARKWAY, ALPHARETTA GA 30004 |
Patrick J Oleary | director | 31515 BALLANTYNE CORP, C/O SPX CORP, CHARLOTTE NC 28277 |
Mojirade James | officer: SVP, General Counsel | 5405 WINDWARD PKWY, ALPHARETTA GA 30004 |
Kerr Holbrook | officer: SVP, GM Chronic Care | 5405 WINDWARD PKWY, ALPHARETTA GA 30004 |
Michael Greiner | officer: SVP - Chief Financial Officer | C/O VISTAPRINT, 95 HAYDEN AVENUE, LEXINGTON MA 02421 |
David Edward Ball | officer: SVP - Global Supply Chain | AVANOS MEDICAL, INC., 5405 WINDWARD PKWY, ALPHARETTA GA 30004 |
William David Haydon | officer: SVP, GM Pain Franchise | 5405 WINDWARD PARKWAY, ALPHARETTA GA 30004 |
Arjun Ranjan Sarker | officer: Senior VP, International | HALYARD HEALTH, INC., 5405 WINDWARD PARKWAY, ALPHARETTA GA 30004 |
Gary Blackford | director | 7700 FRANCE AVENUE SOUTH, EDINA MN 55435 |
Joseph Fralin Woody | director, officer: Chief Executive Officer | 5405 WINDWARD PARKWAY, SUITE 100 SOUTH, ALPHARETTA GA 30004 |
Steven E Voskuil | officer: See Remarks | 5405 WINDWARD PARKWAY, ALPHARETTA GA 30004 |
John W Wesley | director | 5405 WINDWARD PARKWAY, ALPHARETTA GA 30004 |
John Raymond Tushar | officer: President, Global Franchises | HALYARD HEALTH, INC., 5405 WINDWARD PARKWAY, ALPHARETTA GA 30004 |
From GuruFocus
By PRNewswire • 01-04-2024
By PRNewswire PRNewswire • 11-14-2022
By PRNewswire • 10-25-2023
By PRNewswire PRNewswire • 02-15-2022
By PRNewswire PRNewswire • 01-11-2023
By PRNewswire PRNewswire • 06-06-2022
By PRNewswire PRNewswire • 07-06-2022
By PRNewswire PRNewswire • 05-17-2022
By PRNewswire • 01-02-2024
By PRNewswire PRNewswire • 04-27-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.